EUVIMEDOpdag EUVIMED
Übersichtsarbeit

In Silico Exploration of Potential Inhibitors Targeting SARS ‐ CoV ‐2 Non‐Structural Protein 15 (Nsp15): A Comprehensive Overview of Current Research

Behnaz Yazdani, Hajar Sirous iD, Farnoosh Farzam, Shayan Ansarizadeh iD, Mohammadjavad Karimi Taheri iD, Ghazal Pourmohammad-Hosseini iD, Maryam Noei, Kosar Daneshipour, Danial Shakeri, Maryam Houshangi, Vincenzo Calderone, Simone Brogi iD

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70218 ↗

At a glance

Übersichtsarbeit in Chemical Biology & Drug Design, 2025. Written by Behnaz Yazdani and 11 co-authors. Institution: Bioscience Department, Faculty of Science and Technology (FCT), Universitat de Vic-Universitat Central de Catalunya (Uvic-UCC), Vic, Spain. Major MEDLINE topics: Viral Nonstructural Proteins, Antiviral Agents, Endoribonucleases. 131 references. Funded by: Isfahan University of Medical Sciences.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The SARS‐CoV‐2 nonstructural protein 15 (Nsp15) is an endoribonuclease that plays a critical role in viral replication and immune evasion through its NendoU domain. The unique enzymatic mechanism of Nsp15 has attracted considerable attention as a potential therapeutic target, and the identification of its inhibitors could facilitate the development of novel antiviral agents against coronaviruses. Although biochemical and structural studies have provided important insights into Nsp15 function, no comprehensive review has yet focused on computational approaches applied to the discovery of Nsp15 inhibitors. Consequently, this study aims to address this gap by summarizing recent in silico research focused on the structure, function, and inhibition of Nsp15. Special attention is given to inhibitors derived from both natural and synthetic sources, as well as their binding interactions and predicted pharmacological potential. By integrating current computational findings, this review highlights novel prospects for the rational design of Nsp15‐targeted therapeutics to combat SARS‐CoV‐2 and other related pathogenic coronaviruses.

Subjects

MeSH terms (MEDLINE)

Viral Nonstructural ProteinsAntiviral AgentsEndoribonucleasesHumansSARS-CoV-2Computer SimulationCOVID-19COVID-19 Drug TreatmentMolecular Docking SimulationProtein Binding

Author keywords

COVID‐19Nsp15SARS‐CoV‐2computer‐aided drug designdrug discoverynon‐structural‐protein 15

Substances

Viral Nonstructural ProteinsAntiviral AgentsEndoribonucleases

Authors and institutions

  • Bioscience Department, Faculty of Science and Technology (FCT), Universitat de Vic-Universitat Central de Catalunya (Uvic-UCC), Vic, Spain.
  • Bioinformatics Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Department of Molecular Genetics, Biological Sciences Faculty, Tarbiat Modares University, Tehran, Iran.
  • Department of Microbiology, Faculty of Biological Sciences, Flavarjan Branch, Islamic Azad University, Isfahan, Iran.

ORCID profiles: Hajar Sirous, Shayan Ansarizadeh, Mohammadjavad Karimi Taheri, Ghazal Pourmohammad-Hosseini, Simone Brogi

Funding

  • Isfahan University of Medical Sciences

Cite

APA

Yazdani, B., Sirous, H., Farzam, F., Ansarizadeh, S., Karimi Taheri, M., Pourmohammad-Hosseini, G., Noei, M., Daneshipour, K., Shakeri, D., Houshangi, M., Calderone, V., & Brogi, S. (2025). In Silico Exploration of Potential Inhibitors Targeting SARS ‐ CoV ‐2 Non‐Structural Protein 15 (Nsp15): A Comprehensive Overview of Current Research. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70218

Vancouver

Yazdani B, Sirous H, Farzam F, Ansarizadeh S, Karimi Taheri M, Pourmohammad-Hosseini G, et al. In Silico Exploration of Potential Inhibitors Targeting SARS ‐ CoV ‐2 Non‐Structural Protein 15 (Nsp15): A Comprehensive Overview of Current Research. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70218

BibTeX
@article{Yazdani2025,
  author = {Yazdani, Behnaz and Sirous, Hajar and Farzam, Farnoosh and Ansarizadeh, Shayan and Karimi Taheri, Mohammadjavad and Pourmohammad-Hosseini, Ghazal and Noei, Maryam and Daneshipour, Kosar and Shakeri, Danial and Houshangi, Maryam and Calderone, Vincenzo and Brogi, Simone},
  title = {In Silico Exploration of Potential Inhibitors Targeting SARS ‐ CoV ‐2 Non‐Structural Protein 15 (Nsp15): A Comprehensive Overview of Current Research},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70218}
}
Start for free →